These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 6707381)

  • 1. Thrombocytopenia and fever in a patient taking amrinone.
    Rubin SA; Lee S; O'Connor L; Hubenette A; Tober J; Swan HJ
    N Engl J Med; 1979 Nov; 301(21):1185. PubMed ID: 492292
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality of life and long-term mortality in patients with advanced chronic heart failure treated with intermittent low-dose intravenous inotropes in an outpatient setting.
    Chernomordik F; Freimark D; Arad M; Shechter M; Matetzky S; Savir Y; Shlomo N; Peled A; Goldenberg I; Peled Y
    ESC Heart Fail; 2017 May; 4(2):122-129. PubMed ID: 28451448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inotropes do not increase mortality in advanced heart failure.
    Guglin M; Kaufman M
    Int J Gen Med; 2014; 7():237-51. PubMed ID: 24899821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inotrope use and outcomes among patients hospitalized for heart failure: impact of systolic blood pressure, cardiac index, and etiology.
    Kalogeropoulos AP; Marti CN; Georgiopoulou VV; Butler J
    J Card Fail; 2014 Aug; 20(8):593-601. PubMed ID: 24879975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future role of inotropic drugs.
    Poole-Wilson PA
    Drugs; 1986; 32 Suppl 5():27-32. PubMed ID: 3569109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and pharmacodynamics of newer inotropic agents.
    Rocci ML; Wilson H
    Clin Pharmacokinet; 1987 Aug; 13(2):91-109. PubMed ID: 3304772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer positive inotropic agents in the treatment of chronic cardiac failure. Current status and future directions.
    Weber KT; Gill SK; Janicki JS; Maskin CS; Jain MC
    Drugs; 1987 May; 33(5):503-19. PubMed ID: 3297622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pimobendane (UD-CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic cross-over and double-blind study with two different doses.
    Walter M; Liebens I; Goethals H; Renard M; Dresse A; Bernard R
    Br J Clin Pharmacol; 1988 Mar; 25(3):323-9. PubMed ID: 3282531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects associated with the newer inotropic agents.
    Webster MW; Sharpe DN
    Med Toxicol; 1986; 1(5):335-42. PubMed ID: 2878345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic heart failure: a review of recent drug trials.
    Lipkin DP; Poole-Wilson PA
    Br Med J (Clin Res Ed); 1985 Oct; 291(6501):993-6. PubMed ID: 2864977
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy.
    Barnett DB
    Br J Clin Pharmacol; 1989 May; 27(5):527-37. PubMed ID: 2547407
    [No Abstract]   [Full Text] [Related]  

  • 12. Current status of phosphodiesterase inhibitors in the treatment of congestive heart failure.
    Fischer TA; Erbel R; Treese N
    Drugs; 1992 Dec; 44(6):928-45. PubMed ID: 1282864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study.
    DiBianco R; Shabetai R; Silverman BD; Leier CV; Benotti JR
    J Am Coll Cardiol; 1984 Nov; 4(5):855-66. PubMed ID: 6386932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amrinone in acute and long-term therapy].
    Klepzig M; Kleinhans E; Büll U; Strauer BE
    Z Kardiol; 1985 Feb; 74(2):85-90. PubMed ID: 3922139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease.
    Maskin CS; Forman R; Klein NA; Sonnenblick EH; LeJemtel TH
    Am J Med; 1982 Jan; 72(1):113-8. PubMed ID: 7058816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous use of amrinone for the treatment of the failing heart.
    Mancini D; LeJemtel T; Sonnenblick E
    Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amrinone in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS; Sutton MS; Wilson H; Rocci ML
    J Am Coll Cardiol; 1984 May; 3(5):1282-90. PubMed ID: 6707381
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.